Moreover, PIBI-2240 also could reduce the expression of VEGF, HIF-1αand CD31 in the TAE-treated tumor tissue, which resulted in effective inhibition of tumor vascular re-canalization and collateral circulation. This evidence concerns the gene PECAM1 and neoplasm.